Online citations, reference lists, and bibliographies.
← Back to Search

Novel Amphiphilic Carriers: One Step Further In Cancer Management

M. Misran
Published 2016 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
The ideal goal of treatment, and most often the goal in practice, is the successful removal of cancer with near-zero damage to the rest of the body. As cancer is referred to a class of disease, it is unlikely to idealize a single cure for cancer. The attempt to cure cancer has been revolutionized over decades as the underlying processes have revealed more horizons of understanding. Although a number of strategies have been developed, the associated side effects have led the research to enter a new era of nanoengineering and nanotechnology. Designing versatile nanocarriers offer efficient drug delivery applications with enhanced therapeutic benefits of drug. Amphiphilic nanocarriers fall under the heading of such novel carriers which offer high circulation half-life, low risk to benefit ratio of drugs, sustained release and effective targeting. They provide a paradigm for the design of nanocarriers with a broad spectrum of functionality, applicability, and versatility of synthetic drug delivery particles.
This paper references
Nanomedicine in Cardiovascular
C Psarros (2016)
Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects.
Y. Lu (2003)
A redox-responsive mesoporous silica nanoparticle capped with amphiphilic peptides by self-assembly for cancer targeting drug delivery.
D. Xiao (2015)
Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis.
U. Nielsen (2002)
Water insoluble and soluble lipids for gene delivery.
R. Mahato (2005)
Clinical relevance of the molecular mechanisms of resistance to anti-cancer drugs.
M. Links (1999)
Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes.
H. Hosseini (2015)
Nanoparticle and targeted systems for cancer therapy.
L. Brannon-Peppas (2004)
Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles.
R. Fang (2013)
Nanosize and surface charge effects of hydroxyapatite nanoparticles on red blood cell suspensions.
Y. Han (2012)
"Eat me" imaging and therapy.
Vaishali Bagalkot (2016)
Red blood cell-mimicking synthetic biomaterial particles
N. Doshi (2009)
Exploring Cellular Interactions of Liposomes Using Protein Corona Fingerprints and Physicochemical Properties.
A. Bigdeli (2016)
Drug Delivery and Transport to Solid Tumors
S. H. Jang (2004)
Nanoparticles for drug delivery in cancer treatment.
B. Haley (2008)
Permeation of Insulin, Calcitonin and Exenatide across Caco-2 Monolayers: Measurement Using a Rapid, 3-Day System
V. Gupta (2013)
Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation
다츠히로 이시다 (2009)
Liposomes as potential masking agents in sport doping. Part 2: Detection of liposome-entrapped haemoglobin by flow cytofluorimetry.
S. Esposito (2017)
Liposomes as potential masking agents in sport doping. Part 1: analysis of phospholipids and sphingomyelins in drugs and biological fluids by aqueous normal-phase liquid chromatography-tandem mass spectrometry.
S. Esposito (2017)
Mimicking red blood cell lipid membrane to enhance the hemocompatibility of large-pore mesoporous silica.
R. Roggers (2014)
Toward selection of internalizing antibodies from phage libraries.
B. Becerril (1999)
Delivery of molecular and cellular medicine to solid tumors.
Jain (1997)
Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
A. Eberhard (2000)
G Protein-coupled Receptor (GPCR) Signaling via Heterotrimeric G Proteins from Endosomes*
Nikoleta G. Tsvetanova (2015)
Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects.
H. Maeda (2010)
Self-Assembled Nanoparticles Based on Amphiphilic Anticancer Drug-Phospholipid Complex for Targeted Drug Delivery and Intracellular Dual-Controlled Release.
Y. Li (2015)
Strategic Approaches to Optimizing Peptide ADME Properties
Li Di (2014)
Liposomal nanocarriers for plasminogen activators.
Štěpán Koudelka (2016)
Control of tumour vascular permeability.
Baban (1998)
Nanomedicine in Cardiovascular. Nanotechnology and Drug Delivery, Volume Two: Nano-Engineering Strategies and Nanomedicines against Severe Diseases: 257
C Psarros (2016)
Bin Misran M (2015) Drug delivery and innovative pharmaceutical development in mimicking the red blood cell membrane
S Naeem
Liposomal [Beta]Glucan: Preparation, Characterization and Anticancer Activities
M Halwani (2015)
Targeted Drug Delivery in Cancer Therapy
Jaspreet K. Vasir (2005)
Maiseyeu A (2016) “Eat me” imaging and therapy
V Bagalkot (2016)
Liposomal drug delivery systems: from concept to clinical applications.
T. Allen (2013)
Development of polymeric nanoparticulate drug delivery systems: evaluation of nanoparticles based on biotinylated poly(ethylene glycol) with sugar moiety.
I. Kim (2003)
Cancer Therapy with Nanotechnology-Based Drug Delivery Systems: Applications and Challenges of Liposome Technologies for Advanced Cancer Therapy
R. Suzuki (2016)
Liposome: Emerging Trends In Transdermal Drug Delivery
N Thakur (2016)
From biased signalling to polypharmacology: unlocking unique intracellular signalling using pepducins.
R. Carr (2016)
Drug delivery and innovative pharmaceutical development in mimicking the red blood cell membrane
Sumaira Naeem (2015)
Expedient synthesis of functional single-component glycoliposomes using thiol-yne chemistry.
D. Goyard (2016)

Semantic Scholar Logo Some data provided by SemanticScholar